All News

Given an 18-month prognosis for peritoneal mesothelioma in 2007, a mother shares the joy of tapping her son out at his Air Force basic training graduation.

A once-daily oral pill gives patients with symptomatic TGCT another option when surgery could cause more harm than good.

For World NET Cancer Day, CURE answers seven common questions about neuroendocrine tumors, from carcinoid syndrome and Ki-67 to dotatate PET scans and treatment options.

Up to 40% of patients with classic hairy cell leukemia relapse within 10 to 15 years. An NIH researcher explains how adding Rituxan up front may help.

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.

Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.

Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.

In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.

Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.

A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.

A woman treated for DCIS breast cancer with a double mastectomy shares why her smoother recovery left her with survivor guilt and feeling like an impostor.

The FDA granted accelerated approval to Rybrevant Faspro for recurrent or metastatic head and neck cancer that grew after chemotherapy and immunotherapy.

Dr. Sara Hurvitz explains why giving Enhertu before surgery didn't change care for HER2-low, HR-positive early breast cancer, and what patients should know.

Many people with pancreatic cancer can't fully digest food. Here's how pancreatic enzyme replacement therapy (PERT) works, how to take it with meals and snacks, and what side effects to know.

A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.

The Whipple procedure is the main operation for cancer in the head of the pancreas. Here is what is removed, what the hospital stay is like, the complications to know about and how eating changes afterward.

Immunotherapy is a mainstay of lung cancer treatment, and its side effects are different from chemotherapy's. Here are five to know, what they feel like and how care teams treat them.

Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.

Patients with PD-L1-negative non-small cell lung cancer experienced longer progression-free survival with sac-TMT plus Keytruda compared with chemotherapy plus Keytruda in a phase 3 trial.

For National Hospice and Palliative Care Month, answers to common questions about how palliative care differs from hospice, who qualifies, what Medicare covers and how to find a program.

A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.

A breast cancer survivor shares how cancer turned gratitude into an everyday practice and why it's OK when the holidays bring both joy and grief this year.

Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.

HealthCare.gov open enrollment runs Nov. 1, 2026, to Jan. 15, 2027, and the 2027 out-of-pocket ceiling rises to $12,000. Here's what people with cancer should check before picking a plan.

After nearly a year of chemotherapy, a patient with stage 4 pancreatic cancer describes daily life and side effects on Rasonque (daraxonrasib).

For Lung Cancer Awareness Month, answers to common patient questions about biomarker testing in non-small cell lung cancer: which gene changes doctors look for, blood vs. tissue tests, insurance and retesting.

A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.